CE mark Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test Lucid said that key opinion leaders for esophageal disease in Europe are participating in pivotal clinical trials for the test and its collection device. Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay The company has introduced a number of SARS-CoV-2 tests recently, including one for variants of concern and a high-throughput, extraction-free assay. BGI Genomics Nabs CE Mark for Colorectal Cancer Screening Test The real-time PCR test can detect abnormal methylation of SDC2, ADHFE1, and PPP2R5C genes in stool DNA, which are markers for colorectal cancer cells. Genomtec Gets CE-IVD Mark for Saliva-Based Molecular SARS-CoV-2 Test The RT-LAMP-based test does not require nucleic acid purification and can provide results in several minutes, according to the Polish diagnostics firm. Bio Molecular Systems Gets CE-IVD Mark, Australian Approval for Portable PCR Cycler The instrument uses a contactless magnetic induction heating method and a fan for forced-air cooling in order to cycle samples, enabling rapid cycling times. May 10, 2021 BioEcho Life Sciences Gets CE-IVD Mark for Viral RNA/DNA Extraction Kit May 4, 2021 Purigen Biosystems Gets CE Mark for Nucleic Acid Isolation System May 4, 2021 Bio-Rad Laboratories Gets CE Mark for SARS-CoV-2 Kit Apr 27, 2021 C4Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test Apr 26, 2021 Advanced Biological Laboratories Gets CE-IVD Mark for SARS-CoV-2 Variant Assay Apr 21, 2021 Qiagen Nabs CE Mark for High-Throughput SARS-CoV-2 Test Kit Apr 20, 2021 GenomSys Gets CE Mark for MPEG-G Codec Genomic Data Processing Software Suite Apr 16, 2021 Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel Apr 13, 2021 Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit Apr 1, 2021 Altona Diagnostics Nabs CE Mark for HIV-1 Viral Load PCR Assay Mar 25, 2021 Fluxergy Nabs CE-IVD Mark for SARS-CoV-2 POC PCR Test Mar 24, 2021 Novacyt to Get CE Mark for SARS-CoV-2 Variant Test Mar 23, 2021 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test Mar 18, 2021 MicrosensDx Nabs CE Mark for Rapid SARS-CoV-2 LAMP Test Mar 18, 2021 XPhyto Therapeutics, 3a-diagnostics Obtain CE Mark for 25-Minute SARS-CoV-2 PCR Test Mar 9, 2021 Agilent Receives CE Mark for SARS-CoV-2 PCR Test Mar 4, 2021 Luminex Obtains FDA Emergency Use Authorization for Expanded Respiratory Panel With SARS-CoV-2 Mar 3, 2021 Qiagen MDx Sample Processing Platform Garners CE-IVD Mark Mar 2, 2021 Guardant360 CDx Receives CE Mark for Tumor Mutational Profiling and Tagrisso CDx Use Mar 1, 2021 Mobidiag SARS-CoV-2, Influenza A/B, RSV Test Receives CE Mark Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.